
Sign up to save your podcasts
Or
In this episode, we dive into the world of European intellectual property and medtech innovation with Dr. Christian Wende, a German and European Patent Attorney specializing in medical technology at DTS. With a background in mechanical engineering, a Ph.D. in liver dialysis research, and a Master of Laws in European IP law, Christian brings a rare and powerful combination of technical, legal, and clinical insight.
We explore how startups and investors should think about IP strategy in Europe, the impact of the new Unified Patent Court (UPC), the nuances between U.S. and EU patent landscapes, and how IP due diligence is handled during VC rounds and M&A activity. Whether you're a founder, investor, or innovator in medtech or neurotech, this episode is packed with actionable insights.
This episode is sponsored by Black Swan IP – patent strategy and legal support for neurotech innovators. Learn more at www.blackswan-ip.com/
Top 3 Takeaways:
1:30 What is a patent and how is it different in Europe vs the US?
3:30 How far in advance should you be thinking about European patents?
8:15 How did you get into patent law?
10:00 What kind of education is necessary for this?
14:30 What was your role in the Sapiens DBS IP portfolio?
17:15 Sponsorship by blackswan-ip
17:45 What are common issues especially in Merger and Acquisition deals?
27:15 What is one of the biggest mistakes you see neurotech companies do?
30:00 How do you recognize good legal counsel?
32:30 How do your Japanese roots fit into everything?
36:00 Are you knowledgable about the Asian side of medtech?
38:00 Is there anything that we didn't talk about that you wanted to mention?
4.8
1717 ratings
In this episode, we dive into the world of European intellectual property and medtech innovation with Dr. Christian Wende, a German and European Patent Attorney specializing in medical technology at DTS. With a background in mechanical engineering, a Ph.D. in liver dialysis research, and a Master of Laws in European IP law, Christian brings a rare and powerful combination of technical, legal, and clinical insight.
We explore how startups and investors should think about IP strategy in Europe, the impact of the new Unified Patent Court (UPC), the nuances between U.S. and EU patent landscapes, and how IP due diligence is handled during VC rounds and M&A activity. Whether you're a founder, investor, or innovator in medtech or neurotech, this episode is packed with actionable insights.
This episode is sponsored by Black Swan IP – patent strategy and legal support for neurotech innovators. Learn more at www.blackswan-ip.com/
Top 3 Takeaways:
1:30 What is a patent and how is it different in Europe vs the US?
3:30 How far in advance should you be thinking about European patents?
8:15 How did you get into patent law?
10:00 What kind of education is necessary for this?
14:30 What was your role in the Sapiens DBS IP portfolio?
17:15 Sponsorship by blackswan-ip
17:45 What are common issues especially in Merger and Acquisition deals?
27:15 What is one of the biggest mistakes you see neurotech companies do?
30:00 How do you recognize good legal counsel?
32:30 How do your Japanese roots fit into everything?
36:00 Are you knowledgable about the Asian side of medtech?
38:00 Is there anything that we didn't talk about that you wanted to mention?
4,944 Listeners
4,218 Listeners
233 Listeners
43,712 Listeners
111,088 Listeners
15,285 Listeners
10,135 Listeners
901 Listeners
28,636 Listeners